Skip to main content
Fig. 3 | Journal of Pharmaceutical Policy and Practice

Fig. 3

From: Evaluation of the prophylaxis and treatment of COVID-associated coagulopathy

Fig. 3

ISTH algorithm for management of coagulopathy in COVID-19 [33]. Algorithm for the management of coagulopathy in COVID‐19 based on simple laboratory markers. * The list of markers is given in decreasing order of importance. ** Performing fibrinogen assays may not be feasible in many laboratories, but monitoring the levels can be helpful after patient admission. *** Although a specific cut‐off cannot be defined, a three‐ to four‐fold increase in D‐dimer values may be considered significant. Anyone of the values in this table may be regarded as significant

Back to article page
\